Advent will purchase a controlling stake in India’s Suven Pharmaceuticals for at least 63.13 billion rupees ($762 million), triggering an open offer to buy further shares in the family-run firm https://t.co/wmis6kU8KU— Bloomberg (@business) December 26, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


